STOCK COMMENTS / EPS CHANGESApple ( AAPL) estimates, target cut at Morgan Keegan. Shares of AAPL now seen reaching $513, according to Morgan Keegan. Esitmates also reduced, given lower expected iPad and Mac sales. Outperform rating. Chesapeake Midstream ( CHKM) numbers raised at UBS. Shares of CHKM now seen reaching $32, according to UBS. Estimates also increased as $865MM dropdown from Chesapeake adds new growth platform. Domino's Pizza ( DPZ) numbers boosted at Argus. Shares of DPZ now seen reaching $39, according to Argus Research. Estimates also upped, given lower expected operating expenses. F5 Networks ( FFIV) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Checks point to a mixed March. Outperform rating. FMC ( FMC) estimates, target raised at Keybanc. Shares of FMC now seen reaching $109. Estimates also increased, given the company's strong earnings momentum. Buy rating. Medtronic ( MDT) target increased at Citigroup. MDT price target increased to $44, according to Citigroup. Weakest markets are healing, and organic growth looks to accelerate. Buy rating. St. Jude Medical ( STJ) cut from Top Picks List at Kaufman. $42 price target. Riata and Quadra could fall short of near-term expectations. AT&T ( T) estimates reduced at Goldman through 2013, Goldman Sachs said. Company is selling more smartphones. Neutral rating and $32 price target. Varian Medical Systems ( VAR) numbers raised at Citigroup. Shares of VAR now seen reaching $71, according to Citigroup. Estimates also increased on radiation oncology survey results. Neutral rating. Verizon ( VZ) estimates lowered at Goldman through 2013, Goldman Sachs said. Company is spending more on handset subsidies. Buy rating and $45 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.